A Phase I Study on the Pharmacokinetics and Pharmacodynamics of DJT1116PG, a Novel Selective Inhibitor of Sodium-glucose Cotransporter Type 2, in Healthy Individuals at Steady State-Reference-Cited by-同舟云学术

A Phase I Study on the Pharmacokinetics and Pharmacodynamics of DJT1116PG, a Novel Selective Inhibitor of Sodium-glucose Cotransporter Type 2, in Healthy Individuals at Steady State

Published:2020-05 Issue:5 Volume:42 Page:892-905.e3
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Zhang Hong,Liu Jingrui,Zhu Xiaoxue,Li Xiaojiao,Chen Hong,Wu Min,Li Cuiyun,Ding Yanhua

Funder

National Major Scientific and Technological Special Project

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference35 articles.

1. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045;Cho;Diabetes Res Clin Pract,2018

2. Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases;Bashier;Diabetol Metab Syndr,2019

3. China national diabetes and metabolic disorders study group. Prevalence of diabetes among men and women in China;Yang;N Engl J Med,2010

4. Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus;Ojha;Clin Pharmacol,2019

5. Treatment and diagnosis of diabetes mellitus and its complication: advanced approaches;Sen;Mini Rev Med Chem,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sotagliflozin (LX4211) Alleviates Lower Limb Ischemic Reperfusion by Inhibiting Paracrine of Bone Marrow Mesenchymal Stem Cells;Journal of Biomaterials and Tissue Engineering;2021-12-01